Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 10 Jul 2009 Planned number of patients changed from 24 to 18 as reported by ClinicalTrials.gov.
- 10 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Apr 2009 Planned end date changed from 1 Apr 2009 to 1 May 2009 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History